Pharma-Bio Serv, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2024 was -$1.75K, a 65.6% increase year-over-year.
  • Pharma-Bio Serv, Inc. Net Cash Provided by (Used in) Financing Activities for the twelve months ending July 31, 2024 was -$1.73M, a 1.45% increase year-over-year.
  • Pharma-Bio Serv, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.76M, a 50.2% increase from 2022.
  • Pharma-Bio Serv, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$3.53M, a 101% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$1.75M, a 957% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.73M -$1.75K +$3.34K +65.6% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 -$1.74M -$1.72M +$27.7K +1.58% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$1.77M -$7.19K -$7.19K Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$1.76M -$792 +$1.59K +66.7% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 -$1.76M -$5.08K +$4.24K +45.5% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 -$1.76M -$1.75M -$13K -0.75% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$1.75M $0 +$1.78M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$3.53M -$2.38K -$43.5K -106% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 -$3.49M -$9.33K -$9.33K May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 -$3.48M -$1.74M +$52.3K +2.92% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$3.53M -$1.78M -$1.77M -62248% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$1.75M $41.1K +$32.9K +400% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 -$1.79M $0 +$2.78K May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 -$1.79M -$1.79M -$3.72M -193% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $1.93M -$2.85K +$1.73M +99.8% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $205K $8.22K Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 -$2.78K +$427 +13.3% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $1.93M Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 -$1.73M Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q2 2019 -$3.2K +$144 +4.3% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q3 2018 -$1.8M -$1.78M -$1.77M -20151% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 -$32.4K -$3.35K +$39.2K +92.1% May 1, 2018 Jul 31, 2018 10-Q 2018-09-14
Q1 2018 -$71.5K -$3.33K +$8.71K +72.4% Feb 1, 2018 Apr 30, 2018 10-Q 2018-06-14
Q4 2017 -$80.3K -$16.9K -$9.15K -117% Nov 1, 2017 Jan 31, 2018 10-Q 2018-03-19
Q3 2017 -$71.1K -$8.77K -$1.24K -16.5% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 -$69.9K -$42.5K -$29.8K -235% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$40.1K -$12K +$1.89K +13.6% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 -$42K -$7.8K +$26.7K +77.4% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$68.7K -$7.53K +$39.7K +84.1% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 -$108K -$12.7K +$894 +6.58% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 -$109K -$13.9K +$22.8K +62.1% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 -$132K -$34.5K +$58.6K +62.9% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 -$191K -$47.2K +$10.8K +18.6% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 -$202K -$13.6K -$958 -7.58% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 -$201K -$36.8K -$26.5K -257% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 -$174K -$93.2K -$82.8K -800% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 -$91.3K -$58K -$47.8K -471% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 -$43.4K -$12.6K -$2.68K -26.9% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 -$40.8K -$10.3K -$535 -5.48% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 -$40.2K -$10.4K -$111K -110% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $70.4K -$10.2K -$437 -4.5% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 $70.9K -$9.96K -$2.09K -26.5% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $72.9K -$9.76K -$2.06K -26.7% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 $75K $100K +$108K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$32.8K -$9.72K -$2.35K -31.9% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 -$30.5K -$7.87K +$107 +1.34% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$30.6K -$7.7K -$2.31K -42.8% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$28.3K -$7.54K -$3.11K -70.4% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 -$25.2K -$7.37K Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 -$7.98K +$3.78K +32.1% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 -$5.39K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$4.42K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 -$11.8K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.